BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 32189325)

  • 1. The impact of social capital on patients with multiple sclerosis.
    Reyes S; Suarez S; Allen-Philbey K; Thomson A; Giovannoni G
    Acta Neurol Scand; 2020 Jul; 142(1):58-65. PubMed ID: 32189325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantifying the impact of upper limb tremor on the quality of life of people with multiple sclerosis: a comparison between the QUEST and MSIS-29 scales.
    Tang CC; Soh SE; Boonstra F; Noffs G; Kolbe SC; Butzkueven H; Evans A; Van der Walt A
    Mult Scler Relat Disord; 2022 Feb; 58():103495. PubMed ID: 35085981
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validity and reliability of the Finnish version of the Multiple Sclerosis Impact Scale-29.
    Rosti-Otajärvi E; Hämäläinen P; Wiksten A; Hakkarainen T; Ruutiainen J
    Brain Behav; 2017 Jul; 7(7):e00725. PubMed ID: 28729932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple Sclerosis Impact Scale (MSIS-29): relation to established measures of impairment and disability.
    Hoogervorst EL; Zwemmer JN; Jelles B; Polman CH; Uitdehaag BM
    Mult Scler; 2004 Oct; 10(5):569-74. PubMed ID: 15471375
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improving the evaluation of therapeutic interventions in multiple sclerosis: development of a patient-based measure of outcome.
    Hobart JC; Riazi A; Lamping DL; Fitzpatrick R; Thompson AJ
    Health Technol Assess; 2004 Mar; 8(9):iii, 1-48. PubMed ID: 14982653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The multiple sclerosis impact scale (MSIS-29) is a reliable and sensitive measure.
    McGuigan C; Hutchinson M
    J Neurol Neurosurg Psychiatry; 2004 Feb; 75(2):266-9. PubMed ID: 14742602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coping strategies used by patients with relapsing multiple sclerosis from Argentina: correlation with quality of life and clinical features.
    Carnero Contentti E; López PA; Alonso R; Eizaguirre B; Pettinicchi JP; Tizio S; Tkachuk V; Caride A
    Neurol Res; 2021 Feb; 43(2):126-132. PubMed ID: 33040711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spanish validation of a specific measure to assess work-related problems in people with multiple sclerosis: The Multiple Sclerosis Work Difficulties Questionnaire (MSWDQ-23).
    Martínez-Ginés ML; García-Domínguez JM; Forero L; Canal N; Rebollo P; Prefasi D; Honan CA; Maurino J
    Mult Scler Relat Disord; 2018 May; 22():115-119. PubMed ID: 29656271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psychometric properties of the Croatian version of the depression, anxiety, and stress scale-21 and multiple sclerosis impact scale-29 in multiple sclerosis patients.
    Rogić Vidaković M; Šimić N; Poljičanin A; Nikolić Ivanišević M; Ana J; Đogaš Z
    Mult Scler Relat Disord; 2021 May; 50():102850. PubMed ID: 33636617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tried and tested: the psychometric properties of the multiple sclerosis impact scale (MSIS-29) in a population-based study.
    Gray O; McDonnell G; Hawkins S
    Mult Scler; 2009 Jan; 15(1):75-80. PubMed ID: 18829636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patient-reported outcomes and survival in multiple sclerosis: A 10-year retrospective cohort study using the Multiple Sclerosis Impact Scale-29.
    Raffel J; Wallace A; Gveric D; Reynolds R; Friede T; Nicholas R
    PLoS Med; 2017 Jul; 14(7):e1002346. PubMed ID: 28692670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of smoking cessation on multiple sclerosis disease progression.
    Rodgers J; Friede T; Vonberg FW; Constantinescu CS; Coles A; Chataway J; Duddy M; Emsley H; Ford H; Fisniku L; Galea I; Harrower T; Hobart J; Huseyin H; Kipps CM; Marta M; McDonnell GV; McLean B; Pearson OR; Rog D; Schmierer K; Sharrack B; Straukiene A; Wilson HC; Ford DV; Middleton RM; Nicholas R
    Brain; 2022 May; 145(4):1368-1378. PubMed ID: 34623418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Do people with multiple sclerosis want to discuss their long-term prognosis? A nationwide study in Argentina.
    Carnero Contentti E; López PA; Pettinicchi JP; Alonso R; Tizio S; Tkachuk V; Caride A; Galea I
    Mult Scler Relat Disord; 2020 Jan; 37():101445. PubMed ID: 31655266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Possible antecedents and consequences of self-esteem in persons with multiple sclerosis: preliminary evidence from a cross-sectional analysis.
    Dlugonski D; Motl RW
    Rehabil Psychol; 2012 Feb; 57(1):35-42. PubMed ID: 22369115
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estimating a Preference-Based Index for an Eight-Dimensional Health State Classification System for Multiple Sclerosis.
    Goodwin E; Green C; Spencer A
    Value Health; 2015 Dec; 18(8):1025-36. PubMed ID: 26686787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Variability of Multiple Sclerosis Walking Scale and Multiple Sclerosis Impact Scale Scores in People Without Multiple Sclerosis.
    Binshalan T; Buckley E; Nair S; Mcneill A
    Cureus; 2024 Jan; 16(1):e51811. PubMed ID: 38322083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The physical and psychological impact of multiple sclerosis using the MSIS-29 via the web portal of the UK MS Register.
    Jones KH; Ford DV; Jones PA; John A; Middleton RM; Lockhart-Jones H; Peng J; Osborne LA; Noble JG
    PLoS One; 2013; 8(1):e55422. PubMed ID: 23383186
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anxiety in people with multiple sclerosis during the COVID-19 pandemic: A mixed-methods survey.
    Fahy A; Maguire R
    Rehabil Psychol; 2024 May; 69(2):118-128. PubMed ID: 37956089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The longitudinal relationship between the patient-reported Multiple Sclerosis Impact Scale and the clinician-assessed Multiple Sclerosis Functional Composite.
    Costelloe L; O'Rourke K; McGuigan C; Walsh C; Tubridy N; Hutchinson M
    Mult Scler; 2008 Mar; 14(2):255-8. PubMed ID: 17942522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Psychosocial difficulties of individuals with multiple sclerosis: the PARADISE-24 questionnaire.
    Giovannetti AM; Schiavolin S; Raggi A; Quintas R; Cerniauskaite M; Confalonieri P; Mantegazza R; Torri Clerici V; Antozzi C; Brenna G; Leonardi M
    Int J Rehabil Res; 2016 Dec; 39(4):339-345. PubMed ID: 27631722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.